Zantac® Lawsuit

In October 2019, multiple big-box retailers halted sales of Zantac and other popular ranitidine medications. This recall was sparked by new research indicating the presence of NDMA, a harmful carcinogen, in medications containing ranitidine.

Current findings suggest that the ranitidine molecule, when ingested, may be unstable and form NDMA. Now, users may be able to receive compensation from Zantac lawsuit settlements if they are diagnosed with bladder, colon, kidney, pancreatic, or stomach cancer linked to the known carcinogen, NDMA.

Why File a Zantac Lawsuit

Zantac is a prescription and over-the-counter histamine-2 receptor antagonist, meaning the drug works to decrease the amount of acid created by the stomach. Zantac’s active ingredient, ranitidine, has been approved by the U.S. Food and Drug Administration (FDA) to prevent and/or relieve heartburn caused by sour stomach and acid indigestion.

In addition to heartburn relief, ranitidine is also approved to:

  • Treat and prevent stomach ulcers
  • Treat and prevent ulcers in the intestines
  • Treat gastroesophageal reflux disease (GERD)

While ranitidine medications like Zantac may provide heartburn relief, the acid-reducing pills may come with an increased risk of various types of cancer.

New research indicates that the presence of NDMA in drugs like Zantac was the result of an “inherent instability” of the ranitidine molecule. In other words, ranitidine has the potential to form millions of nanograms of cancer-causing NDMA in the human body when ingested.

N-nitrosodimethylamine (NDMA) is a known carcinogen and industrial chemical used in gasoline, rocket fuel, and other petroleum products.

Recent Zantac lawsuits allege that the drug’s manufacturer, Sanofi, failed to warn users that the drug’s main ingredient is unstable — and, when ingested, can form carcinogenic NDMA in the body.

Lawsuits have already been filed in California, Florida, and New Jersey, with Zantac law firms suing Sanofi U.S. Services Inc. for fraud, products liability, and negligence.

If you currently use Zantac or have used it in the past and have developed cancer, you may be able to file a lawsuit against the drug’s manufacturers. Reach out to the Zantac lawyers at Sokolove Law today to learn more and get a free case review.

Recent News About Zantac

  • September 13, 2019: Zantac attorneys file lawsuits in California and Florida, alleging that Sanofi failed to warn consumers that the ranitidine drug contains a known carcinogen.
  • September 17, 2019: A Florida woman files a Zantac lawsuit alleging she developed breast cancer after using the drug for over 20 years.
  • September 23, 2019: Sandoz Inc. issues a voluntary recall of their ranitidine hydrochloride capsules after the detection of an unexpected impurity — NDMA.
  • September 25, 2019: Apotex Corp. issues a nationwide recall of their ranitidine products after tests find NDMA in the medications.
  • September 26, 2019: Ranitidine medications labeled by Walmart, Walgreens, and Rite-Aid and manufactured by Apotex Corp. undergo a voluntary recall issued by the FDA.
  • October 2, 2019: The FDA warns that their testing discovered “unacceptable levels” of NDMA in ranitidine samples.

Zantac Injuries

The Zantac lawyers at Sokolove Law are currently reviewing cases involving cancer associated with Zantac and other ranitidine drugs.

Some cancer diagnoses may be the result of exposure to NDMA, which is classified by the World Health Organization (WHO) as “clearly carcinogenic,” or cancer-causing.

NDMA exposure from Zantac may be linked to:

  • Bladder cancer
  • Colon cancer
  • Kidney cancer
  • Pancreatic cancer
  • Stomach cancer

If you or a loved one are a Zantac user or have used the medication in the past and have now been diagnosed with the cancers listed above, you may wish to pursue a Zantac lawsuit. Zantac settlements or verdicts may result in financial compensation to pay for medical treatments, lost wages, pain and suffering, and other expenses.

Get Legal Help with a Zantac Lawsuit

The most recent lawsuit filed against Zantac’s maker to date claims that the drug has a “critical defect.” If you or a loved one developed cancer after taking Zantac, you know just how critically devastating dangerous drugs can be.

The Zantac attorneys at Sokolove Law know that good health is priceless — but users who have fallen victim to the drug’s health consequences may be able to seek financial compensation with the help of a Zantac law firm.

Take the first step: Start a free case review today.

Author:Sokolove Law
Sokolove Law

The Sokolove Law Content Team consists of writers and editors who work alongside the firm’s attorneys and case managers. The team strives to present the most accurate and relevant information for those who need legal help.

Last modified: January 21, 2020

View 6 Sources
  1. Carcinogen in Zantac and Generics Triggers FDA, EU Probes, Bloomberg News, 9/13/19. https://www.bloomberg.com/news/articles/2019-09-13/europe-will-review-carcinogen-content-of-stomach-acid-treatments

  2. Guidelines for Drinking-Water Quality, 3rd edition including 1st and 2nd addenda, 2008. https://www.who.int/water_sanitation_health/dwq/chemicals/ndmasummary_2ndadd.pdf

  3. Hagens Berman: National Class Action Lawsuit Accuses Sanofi of Concealing Zantac Cancer Risk, 9/13/19. https://finance.yahoo.com/news/hagens-berman-national-class-action-011200403.html

  4. Hagens Berman Files Second Class-Action Lawsuit Regarding Concealed Zantac Cancer Risk, 9/20/19. https://www.hbsslaw.com/cases/zantac-ranitidine-antacid-drug/pressrelease/zantac-ranitidine-antacid-drug-hagens-berman-files-second-class-action-lawsuit-regarding-concealed-zantac-cancer-risk

  5. Hagens Berman: Law Firm Taking on Drug Makers in Zantac Class Action Condemns FDA’s “Reckless” Cover-up of Ranitidine Carcinogen, Press Release dated 10/3/19. https://www.businesswire.com/news/home/20191003005876/en/Hagens-Berman-Law-Firm-Drug-Makers-Zantac

  6. Mary Santorella, et al. v. Sanofi-Aventis U.S. LLC, et al. USDC District of New Jersey, 3:19-cv-18146.